![Edward Qian Profile](https://pbs.twimg.com/profile_images/1122863125953482757/uVcdRIFP_x96.jpg)
Edward Qian
@EdQian
Followers
502
Following
451
Statuses
252
PCCM @vumclung, Informatics @vumcdbmi, co-host of @icucast. Views are my own.
Joined February 2013
It was an honor to be invited to speak at #LIVES2023. This is an excellent conference and Milan is a beautiful city.
Now @EdQian presenting the second-last trial of the President’s session: Clinical trials in Intensive Care chaired by @ElieAzoulay5 @criticcaredoc The #ACORNtrial: Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection Published recently in @JAMA_current: #LIVES2023
2
7
37
@toddrice_ICU thinks he's prepared but he could never prepare enough for what I'm about to bring
🚨 Don't miss out! Join us tomorrow, Sun., Oct. 6, 9:45-10:45 AM ET for a live recording of @IcuCast with Dr. Eddie Qian & Dr. Todd Rice. They'll give their impressions on the clinical trials highlighted at #CHEST2024 and have some fun while doing it!
0
1
2
Please just include your email...
Great discussion about two new RCTs. Or if you are burned out on new trials, listen in to learn about the new (appears useless) "fan mail" button that you can use to agitate @EdQian
0
0
1
So much to cover but we'll get to them all soon! Always a fun discussion
We continue #CCR24 recap by giving (brief) thoughts on the presentations and dive into REVISE evaluating PPIs for stress ulcer PPX in @NEJM Comment if you have a requested order! REVISE: On your fav podcast app: @CritCareReviews
0
0
0
RT @IcuCast: BONUS Episode! We had the pleasure of speaking with @KevinGibbsMD about the #PREOXI trial just presented at #CCR24 and now ava…
0
17
0
RT @sarahlbloom: Network, learn, and grow at the #CCBootCamp2024 🤝💡. From Evidence-Based ICU Airway Management to Heart Failure in the ICU,…
0
4
0
We even share some ideas for new analyses that would add to our understanding of the field! Authors, feel free to cite @IcuCast
New episode! Stress steroids in septic shock from CAP, a 2ndary analysis of the APROCCHSS trial in @LancetRespirMed Then we dive into our mailbag and address questions on driving pressure and the timing of intubation! Anywhere you get your podcasts!
0
0
4
@schistosomnia @DogICUma I was literally thinking about that as I was reading your comment. How did you know? @toddrice_ICU @IcuCast
0
0
1
@giovannilandoni @NEJM Both questions are important. The 2nd one has bothered me. Overall, VL failure rate is low but the "no VL available" situation exists. Do we devote time to keeping DL skills alive? How many DL intubations do you need to maintain the skill? Is that the best thing for patients?
1
1
3
RT @IcuCast: New episode from #ATS2024! We review the presentations from the @NEJM, @JAMA_current, and @ATSBlueEditor combined session. We…
0
3
0
@CatGaoHow @VUMCLung @ATSCritCare From @VUMCMedicineRes! Alexandra did a fantastic job on the project and presenting the work clearly. More to come
0
0
1
It's fascinating reading the landmark articles and getting the idea of the practice at the time that sparked the question. But as times and technology evolve, sometimes we do need to ask ourselves if those old articles still apply, this is a great example. Kudos to the authors!
Episode 37! Glycemic control in the ICU is the topic with NICE-SUGAR and TGC-Fast both from @NEJM . We also mention Mary Lou Retton and the taste of tube feeds... NICE SUGAR: TGC-Fast:
0
0
2
RT @sarahlbloom: Have yall seen the #ccbootcamp2024 schedule yet? Can’t wait for these 2 days! @VUMC_OAP @AprilKapu @meg_shifrin @hugt @tod…
0
4
0
A little shorter than normal but a good discussion and from a journal we don't typically read which makes it more fun!
Episode 36! We talk about TXA in GI bleeds, starting with HALT-IT published in @TheLancet and then specifically in patients with cirrhosis in @HEP_Journal HALT-IT: TXA and cirrhosis:
0
0
5
@kevingbuell presented the individualized treatment effects paper at @ISICEM!
Episode 34! We recap two oxygen target papers published @JAMA_current and presented @ISICEM! We take a more cursory overview on individualized treatment effects because of its complexity. HOT-COVID: ITE:
0
0
2
A great experience and fantastic discussion. Thanks for the opportunity!
📣 Webinar recording and slides now available: "Antibiotic Choice on Renal Outcomes – The ACORN Trial" with @EdQian of @VUMChealth 🔗 #pctGR
0
3
8